The polo-like kinase inhibitor BI 2536 exhibits potent activity against malignant plasma cells and represents a novel therapy in multiple myeloma

Autor: Stewart, Helen J., Kishikova, Lyudmila, Powell, Fiona L., Wheatley, Sally P., Chevassut, Timothy J.
Zdroj: In Experimental Hematology 2011 39(3):330-338
Databáze: ScienceDirect